Search results - ORA - Oxford University Research Archive

1 - 20 of 20

1

Journal article

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group.

Wardle, J, Armitage, J, Collins, R, et al.
1996-07-01

2

Journal article

Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group.

Harris, M, Bron, A, Brown, N, et al.
1995-11-01

3

Journal article

Effects of omega−3 fatty acid supplements on arrhythmias

Parish, S, Mafham, M, Offer, A, et al.
2020-01-27

4

Journal article

Effects of n-3 fatty acid supplements in diabetes mellitus

Ascend Study Collaborative Group, Bowman, L, Mafham, M, et al.
2018-10-18

5

Journal article

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial.

Bulbulia, R, Bowman, L, Wallendszus, K, et al.
2011-12-01

6

Journal article

Absence of effects of prolonged simvastatin therapy on nocturnal sleep in a large randomized placebo-controlled study. Oxford Cholesterol Study Group.

Keech, A, Armitage, J, Wallendszus, K, et al.
1996-10-01

7

Journal article

Effects of aspirin for primary prevention in persons with diabetes mellitus

Bowman, L, Mafham, M, Wallendszus, K, et al.
2018-10-18

8

Journal article

Regarding "Does simvastatin save lives; If so, when and in whom?" - Reply

Bulbulia, R, Bowman, L, Wallendszus, K, et al.
2008-04-01

9

Journal article

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration

Wardle, J, Armitage, J, Collins, R, et al.
1996-07-13

10

Journal article

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.

Armitage, J, Bowman, L, Clarke, R, et al.
2010-06-01

11

Journal article

Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group.

Mitropoulos, K, Armitage, J, Collins, R, et al.
1997-02-01

12

Journal article

Effects of extended-release niacin with laropiprant in high-risk patients.

Landray, M, Haynes, R, Hopewell, J, et al.
2014-07-01

13

Conference item

MRC/BHF heart protection study (HPS): Mortality, cancer incidence and major vascular events during 4 years post-trial follow-up of HPS

Bulbulia, R, Bowman, L, Wallendszus, K, et al.
2007-03-06

14

Journal article

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.

Armitage, J, Bowman, L, Wallendszus, K, et al.
2010-11-08

15

Journal article

Effects of extended release niacin/laropiprant in 25,673 high-risk individuals receiving statin-based therapy: the HPS2-THRIVE randomized placebo-controlled trial

Landray, M, Haynes, R, Hopewell, J, et al.
2014-07-17

16

Journal article

Effects of anacetrapib in patients with atherosclerotic vascular disease

Bowman, L, Hopewell, J, Chen, F, et al.
2017-08-28

17

Journal article

Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study.

Keech, A, Collins, R, MacMahon, S, et al.
1994-02-01

18

Journal article

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial

Parish, S, Mafham, M, Offer, A, et al.
2022-04-08

19

Journal article

Harmonization of large-scale, heterogeneous individual participant adverse event data from randomized trials of statin therapy

Emberson, J, Spata, E, Blackwell, L, et al.
2022

20

Journal article

Comparison of routinely collected data with clinical trial adjudicated direct follow-up: post-hoc analyses of serious cardiovascular events from the United Kingdom-based ASCEND randomized trial

Harper, C, Mafham, M, Herrington, W, et al.
2021-12-28

TO TOP